For pharmaceutical companies, patient safety has always been the priority. That’s why pyrogen detection has become a mandatory Quality Control test for release of any parenteral drug. With the Monocyte Activation Test, the only in vitro test for the detection of the full range of pyrogens (including endotoxin and non-endotoxin pyrogens), it’s now time to move away from animal-based test for pyrogen detection. The new PyroMAT® system provides pharma companies with a robust solution to make the move to in vitro Pyrogen Test with a ready-to use kit!
Merck KGaA, Darmstadt, Germany
Global Product Manager
Chief Scientific Officer
Presented: October 25, 2018
Research. Development. Production.
We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.